Surrozen (NASDAQ:SRZN) Major Shareholder Tcg Crossover Gp Ii, Llc Acquires 12,374 Shares

Surrozen, Inc. (NASDAQ:SRZN) major shareholder Tcg Crossover Gp Ii, Llc acquired 12,374 shares of Surrozen stock in a transaction that occurred on Thursday, March 12th. The stock was acquired at an average price of $24.99 per share, with a total value of $309,226.26. Following the completion of the acquisition, the insider directly owned 657,301 shares in the company, valued at $16,425,951.99. This represents a 1.92% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Tcg Crossover Gp Ii, Llc also recently made the following trade(s):

• On Monday, March 16th, Tcg Crossover Gp Ii, Llc bought 1,190 shares of Surrozen stock. The shares were bought at an average price of $24.99 per share, for a total transaction of $29,738.10.
• On Friday, March 13th, Tcg Crossover Gp Ii, Llc purchased 35,433 shares of Surrozen stock. The shares were bought at an average cost of $24.88 per share, for a total transaction of $881,573.04.
• On Thursday, February 12th, Tcg Crossover Gp Ii, Llc purchased 1,093 shares of Surrozen stock. The shares were bought at an average cost of $23.86 per share, for a total transaction of $26,078.98.
• On Wednesday, February 11th, Tcg Crossover Gp Ii, Llc purchased 17,763 shares of Surrozen stock. The stock was bought at an average price of $23.57 per share, with a total value of $418,673.91.
• On Tuesday, February 3rd, Tcg Crossover Gp Ii, Llc acquired 4,355 shares of Surrozen stock. The shares were bought at an average cost of $21.94 per share, with a total value of $95,548.70.
• On Monday, February 2nd, Tcg Crossover Gp Ii, Llc acquired 731 shares of Surrozen stock. The shares were bought at an average price of $21.38 per share, for a total transaction of $15,628.78.
• On Friday, January 30th, Tcg Crossover Gp Ii, Llc bought 4,271 shares of Surrozen stock. The stock was bought at an average price of $21.39 per share, for a total transaction of $91,356.69.

Surrozen Trading Up 1.2%

NASDAQ:SRZN opened at $25.50 on Tuesday. The company has a market cap of $218.54 million, a PE ratio of -1.14 and a beta of 0.53. The company has a 50 day simple moving average of $23.46 and a two-hundred day simple moving average of $18.20. Surrozen, Inc. has a 12 month low of $5.90 and a 12 month high of $29.59.

Wall Street Analyst Weigh In

A number of analysts recently commented on SRZN shares. Cantor Fitzgerald initiated coverage on Surrozen in a research report on Thursday, February 19th. They set an “overweight” rating and a $40.00 price objective for the company. Wall Street Zen raised Surrozen to a “sell” rating in a research report on Friday, November 28th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Surrozen in a research note on Thursday, January 22nd. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $36.00.

Institutional Investors Weigh In On Surrozen

A number of hedge funds have recently modified their holdings of the business. Ikarian Capital LLC purchased a new stake in shares of Surrozen in the 4th quarter worth $1,487,000. Quadrature Capital Ltd purchased a new position in Surrozen during the fourth quarter valued at $335,000. Millennium Management LLC grew its holdings in Surrozen by 557.1% during the fourth quarter. Millennium Management LLC now owns 721,266 shares of the company’s stock valued at $16,301,000 after purchasing an additional 611,497 shares during the period. Eversept Partners LP grew its holdings in Surrozen by 23.8% during the fourth quarter. Eversept Partners LP now owns 95,286 shares of the company’s stock valued at $2,153,000 after purchasing an additional 18,289 shares during the period. Finally, Balyasny Asset Management L.P. increased its position in Surrozen by 169.3% in the fourth quarter. Balyasny Asset Management L.P. now owns 190,489 shares of the company’s stock worth $4,305,000 after buying an additional 119,757 shares in the last quarter. Institutional investors own 66.57% of the company’s stock.

About Surrozen

Surrozen, Inc is a clinical-stage biopharmaceutical company focused on developing novel therapeutic antibodies that target the Wnt signaling pathway for applications in tissue repair, regeneration and oncology. Founded in 2012 and headquartered in South San Francisco, California, the company leverages its proprietary SurroBody platform to design bispecific antibody molecules capable of modulating Wnt receptor activity with enhanced tissue specificity.

The SurroBody platform enables the generation of high-affinity, dual-binding antibodies engineered to either activate or inhibit Wnt signaling, a pathway critical to cell proliferation, differentiation and homeostasis.